Cite
HARVARD Citation
Page, M. et al. (n.d.). MBCL-15. TOXICITY PROFILE AND RESPONSE TO HIGH DOSE METHOTREXATE, BEVACIZUMAB, AND TEMOZOLOMIDE CHEMOTHERAPY REGIMEN IN CHILDREN WITH RECURRENT MALIGNANT PEDIATRIC BRAIN TUMORS: SINGLE INSTITUTION EXPERIENCE. Neuro-oncology. 20 (2), p. i120. [Online].